Latest News

Tuesday, April 25, 2017 | Epilepsy & Seizure Disorders, Research and Publications

AAN Unveils New Guideline for SUDEP at Annual Meeting

The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have released a new joint guideline for sudden unexpected death in epilepsy (SUDEP) at the AAN Annual Meeting in Boston.…

Read the full story

Monday, April 24, 2017 | Movement Disorders, Personnel/Company News, Research and Publications

Elekta: New Data on Stereotactic Neurosurgery Devices Presented at AANS

Elekta's Leksell Gamma Knife® radiosurgery system has been highlighted in more than 15 scientific presentations at the American Association of Neurological Surgeons (AANS) Annual Meeting&…

Read the full story

Tuesday, April 18, 2017 | FDA Approval/Clearance, Pain & Headache

FDA Releases Non-Invasive VNS Therapy for Pain Associated with Episodic Cluster Headache

The FDA has released the use of gammaCore, a non-invasive vagus nerve stimulator for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore transmits a mild…

Read the full story

Monday, April 17, 2017 | Healthcare Trends, Research and Publications, Stroke & Cerebrovascular

Stroke Hospitalization Rates and Risk Factors Increasing in Young Adults

Rates of acute ischemic stroke are increasing in young adults, new findings suggest (JAMA Neurology, April 10). Investigators analyzed stroke hospitalization rates as well as associated risk factors a…

Read the full story

Wednesday, April 12, 2017 | FDA Approval/Clearance, Movement Disorders, Product Launches and Updates

First Treatment for Tardive Dyskinesia Approved in US

The FDA approved the selective VMAT2 inhibitor Ingrezza (valbenazine, Neurocrine Biosciences), making it the first treatment approved in the US to treat adults with tardive dyskinesia. The efficacy of…

Read the full story

Thursday, April 06, 2017 | Dementia & Cognitive Disorders

B. Smith and Husband Dan Gasby to Receive American Brain Foundation’s PLINA Award

B. Smith and her husband Dan Gasby are the 2017 recipients of the American Brain Foundation’s Public Leadership in Neurology Award (PLINA). Smith is a celebrity chef, restaurateur, supermodel, a…

Read the full story

Tuesday, April 04, 2017 | FDA Approval/Clearance, Movement Disorders, Neuromuscular & Immune Disorders, Phase 3/4 Trials

New Therapy for Chorea Associated with Huntington’s Disease Wins FDA Approval

The FDA approved Austedo (deutetrabenazine, Teva Pharmaceuticals) tablets for the treatment of chorea associated with Huntington’s disease (HD), making it just the second product approved for th…

Read the full story

Thursday, March 30, 2017 | FDA Approval/Clearance, Pain & Headache

FDA Approves Expanded Indication For Qudexy XR Extended Release Capsules

The FDA has approved two supplemental indications for Qudexy XR (topiramate, Upsher-Smith) Extended Release Capsules for use as prophylaxis of migraine headache in adults and adolescents 12 years of a…

Read the full story

Tuesday, March 28, 2017 | Clinical Trials, FDA Approval/Clearance, Neuromuscular & Immune Disorders, Phase 3/4 Trials, Research and Publications, Genentech, Roche

Ocrevus Receives FDA Greenlight for Relapsing, Primary Progressive Forms of Multiple Sclerosis

The FDA has approved Ocrevus (ocrelizumab, Roche/Genentech) for the treatment of both relapsing and primary progressive forms of multiple sclerosis. Ocrelizumab is a humanized antibody that …

Read the full story

Tuesday, March 28, 2017 | Dementia & Cognitive Disorders, Research and Publications

New Evidence Suggests Potential for Blood-Based Alzheimer’s Biomarker

Plasma neurofilament light (NFL) may represent a blood-based, non-invasive biomarker in Alzheimer’s disease (AD), according to new findings published in the JAMA Neurology (March 27, 2017). In a…

Read the full story

Friday, March 24, 2017 | Epilepsy & Seizure Disorders, Pain & Headache, Research and Publications

Review Identifies Antidepressants and AEDs Effective for Nerve Pain

A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain. In findings published in the journal Neurology, resea…

Read the full story

Wednesday, March 22, 2017 | FDA Approval/Clearance, Movement Disorders

Novel Adjunct Agent Approved for Parkinson’s "Off" Periods

The FDA approved Xadago (safinamide, Newron Pharmaceuticals) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing &ld…

Read the full story

Tuesday, March 14, 2017 | Epilepsy & Seizure Disorders

Sunovion Submits NDA to Expand Aptiom Indication to Pediatric Patients

Sunovion Pharmaceuticals has submitted a supplemental new drug application (sNDA) to the FDA to expand the indication for its antiepileptic drug AED Aptiom (eslicarbazepine acetate) to include use as …

Read the full story

Thursday, February 23, 2017 | Research and Publications, Stroke & Cerebrovascular

ISC 2017: STRATIS Registry Re-Affirms Benefits of Mechanical Thrombectomy from Pivotal Acute Ischemic Stroke Trials

Late-breaking results from the STRATIS (Systematic Evaluation of Patients Treated with Neurothrombectomy Devices for Acute Ischemic Stroke) registry re-affirm the benefits of mechanical thrombectomy t…

Read the full story

Thursday, February 23, 2017 | Research and Publications, Stroke & Cerebrovascular

ISC 2017: Integrative Aspiration System Compares Favorably to Stent Retrievers as Frontline Thrombectomy Therapy for Acute Stroke

New research presented at the ongoing International Stroke Conference in Houston suggests that the ADAPT (A Direct Aspiration, First Pass Technique) compares favorably to the use of stent retrievers a…

Read the full story
Load More